benidipine has been researched along with Fibrosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, Y; Wu, G; Xu, K; Xu, M | 1 |
| Baba, A; Ejima, Y; Endo, Y; Kazama, I; Matsubara, M; Toyama, H | 1 |
| Furuta, K; Hongo, M; Ishizaka, N; Koike, K; Matsuzaki, G; Nagai, R; Saito, K; Sakurai, R | 1 |
3 other study(ies) available for benidipine and Fibrosis
| Article | Year |
|---|---|
Benidipine protects kidney through inhibiting ROCK1 activity and reducing the epithelium-mesenchymal transdifferentiation in type 1 diabetic rats.
Topics: Animals; Calcium Channel Blockers; Cell Transdifferentiation; Cytoprotection; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dihydropyridines; Epithelial-Mesenchymal Transition; Fibrosis; Kidney; Male; Rats; Rats, Wistar; rho-Associated Kinases | 2013 |
Benidipine suppresses in situ proliferation of leukocytes and slows the progression of renal fibrosis in rat kidneys with advanced chronic renal failure.
Topics: Animals; Blood Urea Nitrogen; Calcium Channel Blockers; Cell Proliferation; Creatinine; Cytokines; Dihydropyridines; Disease Models, Animal; Disease Progression; Fibrosis; Kidney; Kidney Failure, Chronic; Kv1.3 Potassium Channel; Leukocytes; Male; Nephrectomy; Rats; Rats, Sprague-Dawley | 2014 |
Comparison of vasculoprotective effects of benidipine and losartan in a rat model of metabolic syndrome.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Aorta, Thoracic; Calcium Channel Blockers; Dihydropyridines; Endothelium, Vascular; Fibrosis; Heart; In Vitro Techniques; Losartan; Metabolic Syndrome; Muscle Relaxation; Myocardium; Nitrates; Nitrites; Rats; Rats, Inbred OLETF; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2008 |